Scilliroside

From Wikipedia, the free encyclopedia

Scilliroside

IUPAC name [(3S,6R,8S,9R,10R,13R,14R,17R)-8,14-dihydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,6,7,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate
Identifiers
CAS number	507-60-8
PubChem	441871
	KEGG	C08880^Y
Jmol-3D images	{{#if:CC(=O)O[C@@H]1C[C@@]2([C@H](CC[C@]3([C@@]2(CC[C@@H]3C4=COC(=O)C=C4)O)C)[C@@]5(C1=C[C@H](CC5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O\|Image 1
SMILES CC(=O)O[C@@H]1C[C@@]2([C@H](CC[C@]3([C@@]2(CC[C@@H]3C4=COC(=O)C=C4)O)C)[C@@]5(C1=C[C@H](CC5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O
Properties
Molecular formula	C₃₂H₄₄O₁₂
Molar mass	620.685
Hazards
Main hazards	Toxic
Y (verify) (what is: Y/N?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
Infobox references

Scilliroside is a toxic compound derived from the plant Drimia maritima (syn. Urginea maritima), which is sometimes used as a rodenticide.^[1]

References

↑ el Bahri, L.; Djegham, M.; Makhlouf, M. (2000). "Urginea maritima L. (Squill): A Poisonous Plant of North Africa". Veterinary and Human Toxicology 42 (2): 108–110. PMID 10750179.

Pest control: Rodenticides

Anticoagulants /
Vitamin K antagonists

Coumarins /
4-Hydroxycoumarins

1st generation	Warfarin Coumatetralyl

2nd generation	Brodifacoum Bromadiolone Difenacoum Flocoumafen

1,3-Indandiones

Chlorophacinone
Pindone
Diphacinone

Others

Difethialone

Convulsants

Calciferols

Inorganic compounds

Organochlorine

Organophosphorus

Phosacetim

Metabolic poisons

Others

Cardiac glycosides (C01A)

Bufadienolides

Bufo	Arenobufagin Bufotalin Cinobufagin Marinobufagin

Scilla	Proscillaridin Scilliroside

Cardenolides

Digitalis	Acetyldigitoxin Acetyldigoxin Digitoxin^# Digoxin^# Lanatoside C Deslanoside Metildigoxin Gitoformate

Kalanchoe	Daigremontianin

Strophanthus	Ouabain (g-Strophanthin) k-Strophanthin Cymarin

Thevetia	Peruvoside

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

M: HRT

anat/phys/devp

noco/cong/tumr, sysi/epon, injr

proc, drug (C1A/1B/1C/1D), blte

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.